Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:45 AM
NCT ID:
NCT02345460
Group ID:
EG000
Title:
Treatment (FOLFIRINOX)
Description:
Patients receive FOLFIRINOX regimen comprising irinotecan hydrochloride IV over 90 minutes, oxaliplatin IV over 120 minutes, leucovorin calcium IV over 120 minutes, and fluorouracil IV over 1-2 minutes and then continuously over 46 hours on day 1. Treatment repeats every 14 days for 6 courses in the absence of disease progression or unacceptable toxicity.
Irinotecan Hydrochloride: Given IV
Oxaliplatin: Given IV
Leucovorin Calcium: Given IV
Fluorouracil: Given IV
Laboratory Biomarker Analysis: Correlative studies
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
1
Other Number Affected:
0
Other Number At Risk:
1
Study:
NCT02345460
Results Section:
NCT02345460
Adverse Events Module:
NCT02345460